NIH-funded research NIH-funded research

Investigating immune cells and proteins to understand sarcoidosis severity

Official title: Using high T-bet-expressing cells and Serum Chemokines as Indicators of Disease Severity in Sarcoidosis

Funded at University of California, San Francisco · NIH-10897084 · Data updated 2026-11-12

This study is looking at how certain immune cells and proteins in your blood relate to the severity of sarcoidosis and how well your lungs are working, so we can better understand the disease and improve treatment for patients like you.

More Sarcoidosis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2021
Project endAugust 31, 2026
Funding year2024
Award (this year)$179,958
NIH project number5K23HL156000-04
Project IDNIH-10897084 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with sarcoidosis, particularly those experiencing varying degrees of lung involvement.

Less likely to help

Patients with other respiratory conditions or those without a diagnosis of sarcoidosis may not benefit from this research.

What this research studies

This research focuses on sarcoidosis, a disease that can affect multiple organs, particularly the lungs. It aims to identify specific immune cells and proteins that correlate with the severity of the disease and lung function in patients. By analyzing blood markers linked to inflammation, the study seeks to provide better insights into the disease's progression and treatment responses. Patients will be monitored over time to gather data on these immune markers and their relationship to clinical outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved methods for assessing disease severity in sarcoidosis, potentially guiding more effective treatment strategies.

How similar studies have gone: Previous research has shown promise in using immune markers to assess disease severity in other conditions, suggesting potential for success in this novel approach for sarcoidosis.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Arger, Nicholas Kostandinos — University of California, San Francisco
  • Study coordinator: Arger, Nicholas Kostandinos

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.